Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical trial NCT01197287 · COMPLETED
Trial details
- NCT number
- NCT01197287
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.